Connect with us

Utah

Comparing TriSalus Life Sciences (NASDAQ:TLSI) and Utah Medical Products (NASDAQ:UTMD)

Published

on

Comparing TriSalus Life Sciences (NASDAQ:TLSI) and Utah Medical Products (NASDAQ:UTMD)



TriSalus Life Sciences (NASDAQ:TLSI – Get Free Report) and Utah Medical Products (NASDAQ:UTMD – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, dividends, analyst recommendations, risk, institutional ownership, earnings and valuation.

Profitability

This table compares TriSalus Life Sciences and Utah Medical Products’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
TriSalus Life Sciences N/A N/A -221.65%
Utah Medical Products 33.40% 13.06% 12.30%

Risk & Volatility

TriSalus Life Sciences has a beta of 0.55, meaning that its stock price is 45% less volatile than the S&P 500. Comparatively, Utah Medical Products has a beta of 0.14, meaning that its stock price is 86% less volatile than the S&P 500.

Advertisement

Analyst Recommendations

This is a summary of recent ratings and recommmendations for TriSalus Life Sciences and Utah Medical Products, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TriSalus Life Sciences 0 0 3 0 3.00
Utah Medical Products 0 0 0 0 N/A

TriSalus Life Sciences presently has a consensus target price of $13.33, indicating a potential upside of 129.10%. Given TriSalus Life Sciences’ higher probable upside, research analysts plainly believe TriSalus Life Sciences is more favorable than Utah Medical Products.

Earnings & Valuation

This table compares TriSalus Life Sciences and Utah Medical Products’ gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
TriSalus Life Sciences $21.98 million 7.19 -$59.04 million N/A N/A
Utah Medical Products $50.22 million 4.68 $16.64 million $4.50 14.79

Utah Medical Products has higher revenue and earnings than TriSalus Life Sciences.

Advertisement

Institutional and Insider Ownership

2.6% of TriSalus Life Sciences shares are held by institutional investors. Comparatively, 69.6% of Utah Medical Products shares are held by institutional investors. 76.2% of TriSalus Life Sciences shares are held by insiders. Comparatively, 6.6% of Utah Medical Products shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Utah Medical Products beats TriSalus Life Sciences on 6 of the 11 factors compared between the two stocks.

About TriSalus Life Sciences

(Get Free Report)

TriSalus Life Sciences, Inc., a medical technology company, researches, develops, and sells drug delivery technologies and immune-oncology therapeutics for the treatment of liver and pancreatic cancer. The company offers Pressure Enabled Drug Delivery infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures for patients with liver cancer and metastases; and the Pancreatic Retrograde Venous Infusion device, which is in Phase 1 clinical trial, for locally advanced pancreatic cancer. It also develops nelitolimod, an investigational immunotherapeutic in Phase 1 clinical trial for the treatment of uveal melanoma with liver metastases, hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and locally advanced pancreatic ductal adenocarcinoma. The company serves interventional radiologists, IR technicians, medical oncologists, nursing support, value analysis committee staff, and patients through its sales representatives and sales managers. TriSalus Life Sciences, Inc. was founded in 2009 and is headquartered in Westminster, Colorado.

About Utah Medical Products

(Get Free Report)

Advertisement

Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO, an umbilical vessel catheters, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATHNUTRI-LOK feeding device; PICC-NATE, a percutaneous intraepithelial central venous catheter; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, the company offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies, and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, it provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS, an endoscopic irrigation devices; suprapubic catheterization; LIBERTY, an urinary incontinence treatment and control systems; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN, a tool to manipulate the uterus in laparoscopic procedures. Additionally, it offers DELTRAN, a disposable pressure transducer; high-pressure and piezo-resistive transducer assemblies; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women’s health centers in hospitals, outpatient clinics, and physician’s offices. The company was incorporated in 1978 and is headquartered in Midvale, Utah.



Receive News & Ratings for TriSalus Life Sciences Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for TriSalus Life Sciences and related companies with MarketBeat.com’s FREE daily email newsletter.

Advertisement



Source link

Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Utah

Utah Hockey Club Owner Ryan Smith Builds Buzz With Free Ticket Giveaway

Published

on

Utah Hockey Club Owner Ryan Smith Builds Buzz With Free Ticket Giveaway


When you’re the Utah Hockey Club, giving away 2,000 tickets to a regular-season game is a cause for celebration, not alarm.

After all, not every pro sports team team has an unused inventory of ‘single goal view seats’ that it can tap as a tool to help entice new fans.

Advertisement

It started with a simple tweet from Utah Hockey Club owner Ryan Smith ahead of the club’s home game against the Vancouver Canucks last Wednesday.

In a followup, Smith said that he’d planned to give away the eight seats in his owner’s suite. But when he got more than 700 responses, he decided to open the invitation wider.

In the end, he put 2,000 extra people into Delta Center on top of the usual sold-out crowd of 11,131. And the fans got a good show as Utah staged a third-period rally from a 2-0 deficit before Mikhail Sergachev buried the game-winner on a 2-on-1 with 12 seconds left in overtime.

Acquired in a trade with the Tampa Bay Lightning during the 2024 NHL draft weekend, Sergachev has been a massive difference-maker for the Utah team in its first season in its new home. Helping to fill holes after fellow veteran blueliners John Marino and Sean Durzi went down early with long-term injuries, 26-year-old Sergachev is averaging 25:45 a game, third-most in the entire NHL.

Advertisement

With eight goals and 26 points in 33 games to date, the two-time Stanley Cup winner is also on pace to match his previous career high of 64 points in a season, set in 2022-23.

Another standout has been goaltender Karel Vejmelka. The 28-year-old now sits second in the NHL with 16.5 goals saved above expected according to MoneyPuck, and has amassed a career-best save percentage of .918.

After their vagabond years in Arizona, including their last two seasons as secondary tenants at 4,600-seat Mullett Arena on the campus of Arizona State University, perhaps it should come as no surprise that the re-established Utah team would come out of the gate as road warriors. Unbeaten in regulation in their last eight games, with a record of 6-0-2, they’re up to 11-6-2 on the road this season.

Utah’s home win over Vancouver last Wednesday boosted the squad to 5-5-3 on home ice. The club followed up on Sunday with a 5-4 shootout loss to the Anaheim Ducks, which has the team just outside of the Western Conference wild-card picture with one more game to go before the NHL’s three-day holiday break — hosting the Dallas Stars as part of a 13-game slate on Monday.

On Dec. 2, the Stars earned a 2-1 win at the Delta Center — Utah’s only regulation loss since Nov. 24. The Western Conference standings are tight, but the new club is trending positively toward making the playoffs in its inaugural season. The Coyotes’ only post-season appearance in the franchise’s last 12 years came as part of the expanded 24-team field in the 2020 pandemic bubble, when they eliminated the Nashville Predators in the best-of-three qualifying round before falling to the Colorado Avalanche.

Advertisement

Of the ice, Smith and his wife and co-owner, Ashley, have already helped make winners out of their 31 fellow NHL owners. Smith Entertainment Group’s $1.2 billion purchase of Arizona’s hockey assets last April fueled a 140 percent increase in the valuation of the franchise — a key metric in the league’s 44 percent increase in average valuations in 2024 per Forbes estimates, which dramatically outpaces the growth of the other North American sports over the last year.

The rosy economic picture for the Utah Hockey Club and the league as a whole bodes well for the next round of collective bargaining. While the current deal is not set to expire until the end of the 2025-26 season, commissioner Gary Bettman indicated at the league’s board of governors’ meetings in Florida earlier this month that he and NHL Players’ Association executive director Marty Walsh plan to start formal discussions in February, with an eye toward potentially completing an agreement before the end of this hockey year.



Source link

Continue Reading

Utah

Washington EDGE Lance Holtzclaw transfers to Utah

Published

on

Washington EDGE Lance Holtzclaw transfers to Utah


Lance Holtzclaw has found a new home. The former Washington edge rusher entered the transfer portal after three years on Montlake and has signed with one of the Huskies’ former Pac-12 opponents, the Utah Utes.

Now in the Big 12, coach Kyle Whittingham’s team should be a good fit for the 6-foot-3, 225-pound pass rush specialist, which finished third in the conference in total defense, allowing 329.7 yards per game in its first year in the conference.

The Utes also finished fifth in the conference with 24 sacks, a statistic that Holtzclaw may be able to assist with if he can see the field more often.

In three years with the Huskies, the former three-star recruit who is originally from Dorchester, Massachusetts, played in 26 games and tallied 13 tackles, 2 sacks, and a fumble recovery.

Advertisement

Holtzclaw’s most notable moment in a Husky uniform came in Washington’s 26-21 win over the USC Trojans in November. He came in on fourth down and pressured quarterback Miller Moss, forcing an errant throw in the game’s final seconds. He also completes an effective defensive line trade between the two schools, after the Huskies added a commitment from former Utah defensive tackle Simote Pepa last week.



Source link

Continue Reading

Utah

Dybantsa, Mandaquit lead Utah Prep to ‘Iolani Classic title | Honolulu Star-Advertiser

Published

on

Dybantsa, Mandaquit lead Utah Prep to ‘Iolani Classic title | Honolulu Star-Advertiser




Source link

Advertisement
Continue Reading

Trending